| Literature DB >> 25830990 |
Maria Fernanda Piccoli1, Bruna Dücker Bastos Amorim1, Harley Miguel Wagner2, Daniel Holthausen Nunes3.
Abstract
BACKGROUND: Telemedicine refers to the use of technology as improvement of healthcare delivery to places where distance becomes an obstacle. Its use represents a great potential for dermatology, a specialty whose visual analysis phase is essential in diagnosis.Entities:
Mesh:
Year: 2015 PMID: 25830990 PMCID: PMC4371669 DOI: 10.1590/abd1806-4841.20153163
Source DB: PubMed Journal: An Bras Dermatol ISSN: 0365-0596 Impact factor: 1.896
Outcome of treated lesions based on location
| Invalidation Reason | Number of invalidations per month | Total | ||||||
|---|---|---|---|---|---|---|---|---|
| Jan | Feb | Mar | Apr | May | Jun | Jul | n (%) | |
| Trial examination | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 3 (2.01) |
| Repeated examination | 3 | 0 | 3 | 0 | 0 | 0 | 0 | 6 (4.03) |
| Examination conducted not in accordance with the protocol | 47 | 5 | 30 | 14 | 18 | 9 | 5 | 128 (85.9) |
| Examination with image out of focus | 0 | 5 | 4 | 0 | 2 | 1 | 0 | 12 (8.05) |
| Total | 50 | 10 | 40 | 14 | 20 | 10 | 5 | 149 (100) |
n - absolute number
Compatibility among different skin neoplasias according to suspicion and diagnostic hypothesis
| Types of skin cancer | Compatibility | ||
|---|---|---|---|
| Yes | No | Total | |
| n (%) | n (%) | n (%) | |
|
| |||
| BCC | 28 (21.2) | 104 (78.8) | 132 (71.7) |
| Other skin cancers | 8 (15.4) | 44 (84.6) | 52 (28.3) |
| Total | 36 (19.6) | 148 (80.4) | 184 (100) |
|
| |||
| SCC | 4 (44.44) | 5 (55.56) | 9 (4.89) |
| Other skin cancers | 9 (5.14) | 166 (94.8) | 175 (95.1) |
| Total | 13 (7.07) | 171 (92.9) | 184 (100) |
|
| |||
| MM | 3 (6.98) | 40 (93.02) | 43 (23.4) |
| Other skin cancers | 1 (0.71) | 140 (99.3) | 141 (76.6) |
| Total | 4 (2.17) | 180 (97.8) | 184 (100) |
n - absolute number
Percentage of diagnostic tests applied to each type of skin cancer, according to the examination requested by the primary healthcare network
| Skin neoplasias | Diagnostic tests | ||||
|---|---|---|---|---|---|
| Sensibility (%) | Specificity(%) | Accuracy (%) | PPV (%) | NPV (%) | |
| Basal cell cancer (BCC) | 77.7 | 29.7 | 39.1 | 21.2 | 84.6 |
| squamous cell carcinoma (SCC) | 30.7 | 97.1 | 92.4 | 44.4 | 94.8 |
| Malignant melanoma (MM) | 75.0 | 77.7 | 77.7 | 6.98 | 99.3 |
PPV - positive predictive value; NPV - negative predictive value